Cargando…
Health state utility values for metastatic pancreatic cancer using a composite time trade-off based on the vignette-based approach in Japan
BACKGROUNDS: Limited information is available on the utility values of metastatic pancreatic cancer, focusing on different health statuses, selected chemotherapy, and related grades 1/2 and 3/4 adverse events (AEs). We evaluated Japanese societal-based health-related utility values for metastatic pa...
Autores principales: | Yuki, Takumoto, Yuriko, Sasahara, Hirohito, Narimatsu, Tatsunori, Murata, Manabu, Akazawa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789314/ https://www.ncbi.nlm.nih.gov/pubmed/36564539 http://dx.doi.org/10.1186/s13561-022-00413-8 |
Ejemplares similares
-
Correction: Health state utility values for metastatic pancreatic cancer using a composite time trade-off based on the vignette-based approach in Japan
por: Takumoto, Yuki, et al.
Publicado: (2023) -
Comparative Outcomes of First-Line Chemotherapy for Metastatic Pancreatic Cancer Among the Regimens Used in Japan: A Systematic Review and Network Meta-analysis
por: Takumoto, Yuki, et al.
Publicado: (2022) -
Treatment patterns and cost estimations of systemic chemotherapy for pancreatic cancer in Japan: A retrospective database study
por: Takumoto, Yuki, et al.
Publicado: (2023) -
Personalization of Chemotherapy for Metastatic Pancreatic Cancer
por: Sasahara, Yuriko (Ito), et al.
Publicado: (2014) -
Utility–Privacy Trade-Offs with Limited Leakage for Encoder
por: Shinohara, Naruki, et al.
Publicado: (2023)